Company Filing History:
Years Active: 2014
Title: Gaoping Li - Innovator in Lipid Level Reduction Technologies
Introduction
Gaoping Li is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at reducing lipid levels in the body. His work is crucial in addressing various metabolic disorders.
Latest Patents
Gaoping Li holds a patent for "Compounds, compositions and methods for reducing lipid levels." This technology relates to specific compounds and methods for preventing and treating conditions such as hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. The compounds disclosed in his patent are designed to lower total cholesterol, LDL-cholesterol, and triglycerides while increasing hepatic LDL receptor expression, inhibiting PCSK9 expression, and activating AMP-activated protein kinase. He has 1 patent to his name.
Career Highlights
Li is currently associated with Cvi Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing effective treatments for lipid-related health issues.
Collaborations
Throughout his career, Gaoping Li has collaborated with esteemed colleagues such as Haiyan Liu and Junbo Wang. These partnerships have enhanced the research and development of his innovative solutions.
Conclusion
Gaoping Li's contributions to the field of lipid level reduction are significant and impactful. His innovative compounds and methods hold promise for improving health outcomes related to metabolic disorders.